Literature DB >> 22001585

High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in Practice (QTIP) Study.

David Pickham1, Eric Helfenbein, Julie A Shinn, Garrett Chan, Marjorie Funk, Ann Weinacker, Jia-Ni Liu, Barbara J Drew.   

Abstract

OBJECTIVE: To test the potential value of more frequent QT interval measurement in hospitalized patients.
DESIGN: We performed a prospective, observational study.
SETTING: All adult intensive care unit and progressive care unit beds of a university medical center. PATIENTS: All patients admitted to one of six critical care units over a 2-month period were included in analyses.
INTERVENTIONS: All critical care beds (n = 154) were upgraded to a continuous QT monitoring system (Philips Healthcare).
MEASUREMENTS AND MAIN RESULTS: QT data were extracted from the bedside monitors for offline analysis. A corrected QT interval >500 msecs was considered prolonged. Episodes of QT prolongation were manually over-read. Electrocardiogram data (67,648 hrs, mean 65 hrs/patient) were obtained. QT prolongation was present in 24%. There were 16 cardiac arrests, with one resulting from Torsade de Pointes (6%). Predictors of QT prolongation were female sex, QT-prolonging drugs, hypokalemia, hypocalcemia, hyperglycemia, high creatinine, history of stroke, and hypothyroidism. Patients with QT prolongation had longer hospitalization (276 hrs vs. 132 hrs, p < .0005) and had three times the odds for all-cause in-hospital mortality compared to patients without QT prolongation (odds ratio 2.99 95% confidence interval 1.1-8.1).
CONCLUSIONS: We find QT prolongation to be common (24%), with Torsade de Pointes representing 6% of in-hospital cardiac arrests. Predictors of QT prolongation in the acutely ill population are similar to those previously identified in ambulatory populations. Acutely ill patients with QT prolongation have longer lengths of hospitalization and nearly three times the odds for mortality then those without QT prolongation.

Entities:  

Mesh:

Year:  2012        PMID: 22001585     DOI: 10.1097/CCM.0b013e318232db4a

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  53 in total

1.  Retrospective Diagnosis of Congenital Long QT Syndrome in a Patient With Febrile Syncope.

Authors:  Kory S London; Jessica Zegre-Hemsey; Melanie Root; Alex Kleinmann; Jennifer L White
Journal:  J Emerg Nurs       Date:  2020-03       Impact factor: 1.836

2.  Prolonged corrected QT interval is associated with short-term and long-term mortality in critically ill patients: results from the FROG-ICU study.

Authors:  Tuija Javanainen; Shiro Ishihara; Etienne Gayat; Beny Charbit; Raija Jurkko; Raphaël Cinotti; Alexandre Mebazaa
Journal:  Intensive Care Med       Date:  2019-02-11       Impact factor: 17.440

3.  Development of a risk score for QTc-prolongation: the RISQ-PATH study.

Authors:  Eline Vandael; Bert Vandenberk; Joris Vandenberghe; Isabel Spriet; Rik Willems; Veerle Foulon
Journal:  Int J Clin Pharm       Date:  2017-03-09

4.  Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs.

Authors:  Anita N Bindraban; José Rolvink; Florine A Berger; Patricia M L A van den Bemt; Aaf F M Kuijper; Ruud T M van der Hoeven; Aukje K Mantel-Teeuwisse; Matthijs L Becker
Journal:  Int J Clin Pharm       Date:  2018-07-26

5.  Lead electrocardiogram changes after supratentorial intracerebral hemorrhage.

Authors:  Dan Popescu; Cristina Laza; Athena Mergeani; Ovidiu Alexandu Bajenaru; Florina Anca Antochi
Journal:  Maedica (Buchar)       Date:  2012-12

6.  QT interval prolongation in hospitalized patients on cardiology wards: a prospective observational study.

Authors:  Qasim Khan; Mohammad Ismail; Iqbal Haider; Inam Ul Haq; Sidra Noor
Journal:  Eur J Clin Pharmacol       Date:  2017-08-12       Impact factor: 2.953

7.  Sex-related differences in the effect-site concentration of remifentanil for preventing QTc interval prolongation following intubation in elderly patients with a normal QTc interval.

Authors:  S Y Kim; M K Song; M-S Kim; E H Kim; D W Han
Journal:  Drugs Aging       Date:  2014-09       Impact factor: 3.923

8.  Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients.

Authors:  James E Tisdale; Heather A Jaynes; Joanna R Kingery; Brian R Overholser; Noha A Mourad; Tate N Trujillo; Richard J Kovacs
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-05-06

Review 9.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

10.  Development and validation of a risk score to predict QT interval prolongation in hospitalized patients.

Authors:  James E Tisdale; Heather A Jaynes; Joanna R Kingery; Noha A Mourad; Tate N Trujillo; Brian R Overholser; Richard J Kovacs
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.